Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -1.55 is 125% below its 5-year average of -0.69, near the low end of its 5-year range (-3.02–6.74).
As of the fiscal period ended Tuesday, June 30, 2026. 627.04% below its 12-month average of -0.21.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -1.55.
DEBT TO EQUITY RATIO
-1.55
DEBT TO EQUITY RATIO AVG TTM
-0.21
DEBT TO EQUITY RATIO AVG 3Y
-1.06
DEBT TO EQUITY RATIO AVG 5Y
-0.69
DEBT TO EQUITY RATIO AVG 10Y
-1.20
DEBT TO EQUITY RATIO AVG 15Y
-0.70
DEBT TO EQUITY RATIO AVG 20Y
-0.26
CURRENT VS TTM AVG
-627.04%
CURRENT VS 3Y AVG
-46.58%
CURRENT VS 5Y AVG
-125.12%
CURRENT VS 10Y AVG
-29.06%
CURRENT VS 15Y AVG
-120.55%
CURRENT VS 20Y AVG
-490.04%
SECTOR MEDIAN · HEALTHCARE
0.11
median of 774 covered companies
CURRENT VS SECTOR MEDIAN
-1509.11%
vs the sector median at left
Market Cap
$1.82B
Debt to Equity Ratio
0.68
TTM Avg
0.90
3Y Avg
1.91
5Y Avg
1.72
Market Cap
$1.82B
Debt to Equity Ratio
0.45
TTM Avg
0.51
3Y Avg
0.29
5Y Avg
0.25
Market Cap
$1.80B
Debt to Equity Ratio
0.14
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.85B
Debt to Equity Ratio
1.18
TTM Avg
1.02
3Y Avg
0.74
5Y Avg
0.70
Market Cap
$1.87B
Debt to Equity Ratio
0.00
TTM Avg
0.01
3Y Avg
0.01
5Y Avg
0.14
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novavax, Inc. (NVAX) | $1.82B | -1.55 | -0.21 | -1.06 | -0.69 |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.82B | 0.68 | 0.90 | 1.91 | 1.72 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 0.45 | 0.51 | 0.29 | 0.25 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.80B | 0.14 | N/A | N/A | N/A |
| Astrana Health, Inc. (ASTH)vs › | $1.85B | 1.18 | 1.02 | 0.74 | 0.70 |
| Azenta, Inc. (AZTA)vs › | $1.85B | 0.04 | 0.05 | 0.03 | 0.05 |
| Xencor, Inc. (XNCR)vs › | $1.79B | 0.13 | 0.32 | 0.21 | 0.15 |
| Novocure Ltd (NVCR)vs › | $1.78B | 0.69 | 1.38 | 1.43 | 1.35 |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.87B | 0.00 | 0.01 | 0.01 | 0.14 |
| Surgery Partners, Inc. (SGRY)vs › | $1.77B | 2.40 | 2.21 | 1.86 | 2.71 |
Debt/Equity
-1.55
Current Ratio
2.33
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -1.55 |
| 2026-03-31 | -2.04 |
| 2025-12-31 | -1.95 |
| 2025-09-30 | -1.60 |
| 2025-06-30 | 6.07 |
| 2025-03-31 | -3.02 |
| 2024-12-31 | -0.37 |
| 2024-09-30 | -0.44 |
| 2024-06-30 | -0.54 |
| 2024-03-31 | -0.26 |
| 2023-12-31 | -0.32 |
| 2023-09-30 | -0.33 |
| 2023-06-30 | -0.26 |
| 2023-03-31 | -0.22 |
| 2022-12-31 | -0.87 |
| 2022-09-30 | -0.77 |
| 2022-06-30 | -1.08 |
| 2022-03-31 | 6.74 |
| 2021-12-31 | -1.29 |
| 2021-09-30 | 0.93 |
| 2021-06-30 | 0.58 |
| 2021-03-31 | 0.44 |
| 2020-12-31 | 0.75 |
| 2020-09-30 | 4.14 |
| 2020-06-30 | 1.74 |
| 2020-03-31 | -13.39 |
| 2019-12-31 | -1.73 |
| 2019-09-30 | -1.69 |
| 2019-06-30 | -1.72 |
| 2019-03-31 | -2.15 |
| 2018-12-31 | -1.90 |
| 2018-09-30 | -2.52 |
| 2018-06-30 | -3.63 |
| 2018-03-31 | -3.20 |
| 2017-12-31 | -3.12 |
| 2017-09-30 | -4.28 |
| 2017-06-30 | -5.37 |
| 2017-03-31 | -10.88 |
| 2016-12-31 | -57.04 |
| 2016-09-30 | 6.35 |
| 2016-06-30 | 2.87 |
| 2016-03-31 | 1.70 |
| 2015-12-31 | 0.00 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 0.00 |
| 2014-09-30 | 0.01 |
| 2014-06-30 | 0.01 |
| 2014-03-31 | 0.01 |
| 2013-12-31 | 0.01 |
| 2013-09-30 | 0.01 |
| 2013-06-30 | 0.04 |
| 2013-03-31 | 0.03 |
| 2012-12-31 | 0.02 |
| 2012-09-30 | 0.02 |
| 2012-06-30 | 0.01 |
| 2012-03-31 | 0.01 |
| 2011-12-31 | 0.01 |
| 2011-09-30 | 0.01 |
| 2011-06-30 | 0.01 |
| 2011-03-31 | 0.01 |
| 2010-12-31 | 0.01 |
| 2010-09-30 | 0.01 |
| 2010-06-30 | 0.01 |
| 2010-03-31 | 0.01 |
| 2009-12-31 | 0.01 |
| 2009-09-30 | 0.01 |
| 2009-06-30 | 0.10 |
| 2009-03-31 | 0.60 |
| 2008-12-31 | 0.50 |
| 2008-09-30 | 0.39 |
| 2008-06-30 | 0.47 |
| 2008-03-31 | 0.41 |
| 2007-12-31 | 0.36 |
| 2007-09-30 | 0.31 |
| 2007-06-30 | 0.28 |
| 2007-03-31 | 0.27 |
| 2006-12-31 | 0.25 |
| 2006-09-30 | 0.23 |
| 2006-06-30 | 0.22 |
| 2006-03-31 | 0.21 |
| 2005-12-31 | 0.61 |
| 2005-09-30 | 1.82 |
| 2005-06-30 | 1.95 |
| 2005-03-31 | 1.51 |
| 2004-12-31 | 1.12 |
| 2004-09-30 | 0.84 |
| 2004-06-30 | 1.78 |
| 2004-03-31 | 1.36 |
| 2003-12-31 | 1.17 |
| 2003-09-30 | 3.24 |
| 2003-06-30 | 2.58 |
| 2003-03-31 | 2.11 |
| 2002-12-31 | 5.13 |
| 2002-09-30 | 3.07 |
